Clinical Trial Update: Evaluation of Cytokine Biomarkers in Melanoma Patients During Immunotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cytokine biomarkers in melanoma patients undergoing immunotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Blokhin's Russian Cancer Research Center | Conditions: Melanoma | Phase 2 | Status: UNKNOWN